ArticleThe Lancet. Oncology2023

Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.

Adam M Sonabend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.